Nanoplatelets modified with RVG for targeted delivery of miR-375 and temozolomide to enhance gliomas therapy.

MLA

Yang, Tingting, et al. “Nanoplatelets Modified with RVG for Targeted Delivery of MiR-375 and Temozolomide to Enhance Gliomas Therapy.” Journal of Nanobiotechnology, vol. 22, no. 1, Oct. 2024, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12951-024-02895-6.

APA

Yang, T., Zhang, N., Liu, Y., Yang, R., Wei, Z., Liu, F., Song, D., Wang, L., Wei, J., Li, Y., Shen, D., & Liang, G. (2024). Nanoplatelets modified with RVG for targeted delivery of miR-375 and temozolomide to enhance gliomas therapy. Journal of Nanobiotechnology, 22(1), 1–15. https://doi.org/10.1186/s12951-024-02895-6

Chicago

Yang, Tingting, Nan Zhang, Yuanyuan Liu, Ruyue Yang, Zhaoyi Wei, Futai Liu, Dan Song, et al. 2024. “Nanoplatelets Modified with RVG for Targeted Delivery of MiR-375 and Temozolomide to Enhance Gliomas Therapy.” Journal of Nanobiotechnology 22 (1): 1–15. doi:10.1186/s12951-024-02895-6.